Top

Neurological Sciences

Published in:

Open Access 17-05-2022 | Stroke | Original Article

Elevated troponin I levels on admission predict long-term mortality in patients with acute cerebral infarction following thrombolysis

Authors: Yuehong Huang, Yanqi Shao, Yiqi Wang, Tianming Shi

Published in: Neurological Sciences | Issue 9/2022

Abstract

Background/objective

Cardiac diseases are frequently accompanied by elevated levels of biomarkers, among which, troponin is commonly investigated. The levels of plasma cardiac troponin I (cTnI), which has been shown to predict short-term mortality, are elevated in patients with acute cerebral infarction (ACI). However, few studies have assessed the association between cTnI concentration and long-term mortality in patients with ACI following thrombolysis.

Methods

Patients with ACI admitted between January 1, 2014, and December 31, 2016, were registered. Data on demographics and outcomes with elevated cTnI levels were also collected.

Results

A total of 145 patients with ACI were recruited; 97 (66%), 30 (20%), and 18 (12%) patients had cTnI concentrations < 0.030 (group 1), 0.030–0.10 (group 2), and > 0.10 μg/L (group 3), respectively. cTnI elevation was associated with older age, atrial fibrillation, congestive heart failure, renal insufficiency, coronary artery disease, stroke severity (National Institutes of Health Stroke Scale score), and prior smoking history at admission. After adjusting for comorbidities and severity at 3 months after ACI, cTnI elevation on admission was significantly associated with ascending 5-year mortality (hazard ratio, 1.80; 95% confidence interval, 1.22–2.65).

Conclusions

Even after adjusting for several possible confounders, cTnI elevation in patients with ACI treated with rt-PA was associated with a 1.80-fold increased risk of 5-year mortality.

Hasırcı B, Okay M, Ağırcan D, Koçer A et al (2013) Elevated troponin level with negative outcome was found in ischemic stroke. Cardiovasc Psychiatry Neurol 2013:953672. https://doi.org/10.1155/2013/953672:953672CrossRefPubMedPubMedCentral

Anetsberger A, Jungwirth B, Blobner M et al (2021) Association of troponin T levels and functional outcome 3 months after subarachnoid hemorrhage. Sci Rep 11:16154. https://doi.org/10.1038/s41598-021-95717-wCrossRefPubMedPubMedCentral

Flores-Solís LM, Hernández-Domínguez JL (2014) Cardiac troponin I in patients with chronic kidney disease stage 3 to 5 in conditions other than acute coronary syndrome. Clin Lab 60:281–290. https://doi.org/10.7754/clin.lab.2013.121103CrossRefPubMed

Zhang N, Wang C, Zhu F et al (2020) Risk factors for poor outcomes of diabetes patients with COVID-19: a single-center, retrospective study in early outbreak in China. Front Endocrinol (Lausanne) 11:571037. https://doi.org/10.3389/fendo.2020.571037CrossRef

Henzler T, Roeger S, Meyer M et al (2012) Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction. Eur Respir J 39:919–926. https://doi.org/10.1183/09031936.00088711CrossRefPubMed

Morris PG, Chen C, Steingart R et al (2011) Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib. Clin Cancer Res 17:3490–3499. https://doi.org/10.1158/1078-0432.CCR-10-1359CrossRefPubMed

Welsh P, Tuckwell K, McInnes IB, Sattar N (2016) Effect of IL-6 receptor blockade on high-sensitivity troponin T and NT-proBNP in rheumatoid arthritis. Atherosclerosis 254:167–171. https://doi.org/10.1016/j.atherosclerosis.2016.10.016CrossRefPubMedPubMedCentral

Mayer O, Seidlerová J, Bruthans J et al (2015) The predictive potential of asymptomatic mild elevation of cardiac troponin I on mortality risk of stable patients with vascular disease. Clin Biochem 48:353–357. https://doi.org/10.1016/j.clinbiochem.2014.07.022CrossRefPubMed

Scheitz JF, Endres M, Mochmann HC, Audebert HJ, Nolte CH (2012) Frequency, determinants and outcome of elevated troponin in acute ischemic stroke patients. Int J Cardiol 157:239–242. https://doi.org/10.1016/j.ijcard.2012.01.055CrossRefPubMed

10.

Jauch EC, Saver JL, Adams HP et al (2013) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 44:870–947. https://doi.org/10.1161/STR.0b013e318284056aCrossRefPubMed

11.

Sui Y, Liu T, Luo J, Xu B et al (2019) Elevation of high-sensitivity cardiac troponin T at admission is associated with increased 3-month mortality in acute ischemic stroke patients treated with thrombolysis. Clin Cardiol 42:881–888. https://doi.org/10.1002/clc.23237CrossRefPubMedPubMedCentral

12.

Di Angelantonio E, Fiorelli M, Toni D et al (2005) Prognostic significance of admission levels of troponin I in patients with acute ischaemic stroke. J Neurol Neurosurg Psychiatry 76:76–81. https://doi.org/10.1136/jnnp.2004.041491CrossRefPubMed

13.

Scheitz JF, Erdur H, Haeusler KG et al (2015) Insular cortex lesions, cardiac troponin, and detection of previously unknown atrial fibrillation in acute ischemic stroke: insights from the troponin elevation in acute ischemic stroke study. Stroke 46:1196–1201. https://doi.org/10.1161/STROKEAHA.115.008681CrossRefPubMed

14.

National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581–1587. https://doi.org/10.1056/NEJM199512143332401CrossRef

15.

Hartmann A, Rundek T, Mast H, Paik MC, Boden-Albala B, Mohr JP, Sacco RL (2001) Mortality and causes of death after first ischemic stroke: the Northern Manhattan Stroke Study. Neurology 57:2000–2005. https://doi.org/10.1212/wnl.57.11.2000CrossRefPubMed

16.

Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24:35–41. https://doi.org/10.1161/01.str.24.1.35CrossRefPubMed

17.

Brott T, Adams HP, Olinger CP et al (1989) Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864–870. https://doi.org/10.1161/01.str.20.7.864CrossRefPubMed

18.

James P, Ellis CJ, Whitlock RM, McNeil AR, Henley J, Anderson NE (2000) Relation between troponin T concentration and mortality in patients presenting with an acute stroke: observational study. BMJ 320:1502–1504. https://doi.org/10.1136/bmj.320.7248.1502CrossRefPubMedPubMedCentral

19.

Beaulieu-Boire I, Leblanc N, Berger L, Boulanger JM (2013) Troponin elevation predicts atrial fibrillation in patients with stroke or transient ischemic attack. J Stroke Cerebrovasc Dis 22:978–983. https://doi.org/10.1016/j.jstrokecerebrovasdis.2012.01.008CrossRefPubMed

20.

Ahn SH, Lee JS, Kim YH et al (2017) Prognostic significance of troponin elevation for long-term mortality after ischemic stroke. J Stroke 19:312–322. https://doi.org/10.5853/jos.2016.01942 (28877565)CrossRefPubMedPubMedCentral

21.

Barber M, Morton JJ, Macfarlane PW, Barlow N, Roditi G, Stott DJ (2007) Elevated troponin levels are associated with sympathoadrenal activation in acute ischaemic stroke. Cerebrovasc Dis 23:260–266. https://doi.org/10.1159/000098325CrossRefPubMed

22.

Faiz KW, Thommessen B, Einvik G, Omland T, Rønning OM (2014) Prognostic value of high-sensitivity cardiac troponin T in acute ischemic stroke. J Stroke Cerebrovasc Dis 23:241–248. https://doi.org/10.1016/j.jstrokecerebrovasdis.2013.01.005CrossRefPubMed

23.

Hacke W, Kaste M, Bluhmki E,et al.(2008) Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 359(13):1317–1329. https://doi.org/10.1056/NEJMoa0804656CrossRefPubMed

24.

Thålin C, Rudberg AS, Johansson F et al (2015) Elevated troponin levels in acute stroke patients predict long-term mortality. J Stroke Cerebrovasc Dis 24:2390–2396. https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.06.043CrossRefPubMed

25.

Fang MC, Go AS, Chang Y, Borowsky LH, Pomernacki NK, Udaltsova N, Singer DE (2014) Long-term survival after ischemic stroke in patients with atrial fibrillation. Neurology 82:1033–1037. https://doi.org/10.1212/WNL.0000000000000248CrossRefPubMedPubMedCentral

26.

Berkhemer OA, Fransen PS, Beumer D et al (2015) A randomized trial of intraarterial treatment for acute ischemic stroke. N Engl J Med 372:11–20. https://doi.org/10.1056/NEJMoa1411587CrossRefPubMed

27.

Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R (1996) “Malignant” middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53:309–315. https://doi.org/10.1001/archneur.1996.00550040037012CrossRefPubMed

28.

Cao YZ, Zhao LB, Liu S et al (2019) Prognostic value of elevated high-sensitivity cardiac troponin T levels in patients with acute ischemic stroke treated with endovascular thrombectomy. J Clin Neurosci 64:145–149. https://doi.org/10.1016/j.jocn.2019.03.030CrossRefPubMed

29.

Sabatine MS, Morrow DA, de Lemos JA, Jarolim P, Braunwald E (2009) Detection of acute changes in circulating troponin in the setting of transient stress test-induced myocardial ischaemia using an ultrasensitive assay: results from TIMI 35. Eur Heart J 30:162–169. https://doi.org/10.1093/eurheartj/ehn504CrossRefPubMed

30.

Lasek-Bal A, Kowalewska-Twardela T, Gąsior Z, Warsz-Wianecka A, Haberka M, Puz P, Ziaja D (2014) The significance of troponin elevation for the clinical course and outcome of first-ever ischaemic stroke. Cerebrovasc Dis 38:212–218. https://doi.org/10.1159/000365839CrossRefPubMed

31.

Jensen JK, Hallén J, Lund T, Madsen LH, Grieg Z, Januzzi JL, Atar D (2011) Troponin I degradation in serum of patients with acute ischemic stroke. Scand J Clin Lab Invest 71:74–80. https://doi.org/10.3109/00365513.2010.542485CrossRefPubMed

32.

Cechetto DF, Wilson JX, Smith KE et al (1989) Autonomic and myocardial changes in middle cerebral artery occlusion: stroke models in the rat. Brain Res 502:296–305. https://doi.org/10.1016/0006-8993(89)90625-2CrossRefPubMed

33.

Mochmann HC, Scheitz JF, Petzold GC et al (2016) Coronary angiographic findings in acute ischemic stroke patients with elevated cardiac troponin: the troponin elevation in acute ischemic stroke (TRELAS) study. Circulation 133:1264–1271. https://doi.org/10.1161/CIRCULATIONAHA.115.018547CrossRefPubMed

34.

Katan M, Elkind MS (2018) The potential role of blood biomarkers in patients with ischemic stroke:an expert opinion. Clin Transl Neurosci 2:X18768050. https://doi.org/10.1177/2514183X18768050CrossRef

Title: Elevated troponin I levels on admission predict long-term mortality in patients with acute cerebral infarction following thrombolysis
Authors: Yuehong Huang
Yanqi Shao
Yiqi Wang
Tianming Shi
Publication date: 17-05-2022
Publisher: Springer International Publishing
Keyword: Stroke
Published in: Neurological Sciences / Issue 9/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06116-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Elevated troponin I levels on admission predict long-term mortality in patients with acute cerebral infarction following thrombolysis

Abstract

Background/objective

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background/objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 9/2022

REM sleep behavior disorder as a remote precedent to Creutzfeldt-Jakob disease

Increase pain sensitivity during the four phases of the migraine cycle in patients with episodic migraine

A rank subdivision of equivalent score for enhancing neuropsychological test norms

Mindfulness and other behavioral approaches

Relationship between neutrophil to lymphocyte ratio and intracranial hemorrhage in stroke

Floating aortic arch thrombus involving the left common carotid artery complicated with ischemic stroke associated with cocaine use